This study investigates pancreatic ductal adenocarcinoma. The purpose of this study is to evaluate treatments for adults with this condition who also experience significant weight loss and fatigue.
The study focuses on evaluating the safety, effectiveness, and tolerability of an investigational medication when used alongside chemotherapy. Researchers are interested in understanding how this combination works for people with this condition.
- Who can participate: Adults diagnosed with metastatic pancreatic ductal adenocarcinoma and cachexia can participate if they have completed specific chemotherapy cycles and have an ECOG performance status of 1 or less.
- Study details: Participants will receive either the investigational medication or a placebo along with chemotherapy. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand